Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-011258

SVP, COO & CFO sold 5,938 shares at $22.35 ($132,714)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2020-02-18 Sale −5,938 $22.35 $132,714 253,221 D: show line 1 in the form
Open-market sales · 5,938 sh · avg $22.35 · $132,714
Loading xslF345X03/doc4.xml…